Compass Pathways (CMPS)

• Market cap: $1.76B
• 1 day: 9.56%
• 5 days: 8.47%
• 1 month: 55.85%
• 3 months: 86.04%
• 6 months: 149.24%
• Year to date: 99.39%
• 1 year: 215.46%
• 5 years: -62.1%
• 10 years: -54.97%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Employees: 156